Quantum Immunologics, Inc. Press releases
1 - 1 of 1 Press Release
Nov 19, 2010
Quantum Immunologics, Inc. (“QI”), a Tampa-based company currently engaged in an FDA-authorized clinical study of its autologous dendritic cell immunotherapy for Stage IV breast cancer patients.